2009-2010 年配方(疫苗），NR-1_Vaccinia virus

NR-19879?? Fluzone? Influenza Virus Vaccine, 2009-2010 Formula(Vaccines)|Influenza A & B viruses|Fluzone? Influenza Virus Vaccine, 2009-2010 Formula|2°C to 8°C|NIAID/NIHAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Fluzone? Influenza Virus Vaccine, 2009-2010 Formula, NR-19879."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.NR-19879 is a split-virus vaccine prepared from influenza viruses A/Brisbane/59/2007 IVR-148 (H1N1), A/Uruguay/716/2007 NYMC X-175C (H3N2) [an A/Brisbane/10/2007 (H3N2)-like virus] and B/Brisbane/60/2008 that were predicted to circulate in the United States during the 2009 to 2010 influenza season.The hemagglutinin content was standardized according to U.S. Public Health Service requirements. Each 0.5 mL syringe contains the recommended ratio of 15 ?g each of the hemagglutinin antigens from influenza viruses A/Brisbane/59/2007 IVR-148 (H1N1), A/Uruguay/716/2007 NYMC X-175C (H3N2) and B/Brisbane/60/2008.Please note that this vaccine preparation is being released for research use only and not for human use. Vaccines produced for the 2009-2010 season are now past their expiration dates.Each syringe contains 0.5 mL of split-virus vaccine in phosphate-buffered saline containing 0.05% gelatin. The product was formulated without preservatives.

NR-19878?? Fluzone? Influenza Virus Vaccine, 2009-2010 Formula(Vaccines)|Influenza A & B viruses|Fluzone? Influenza Virus Vaccine, 2009-2010 Formula|2°C to 8°C|NIAID/NIHAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Fluzone^? Influenza Virus Vaccine, 2009-2010 Formula, NR-19878."|Quantity limit per order for this item is 3. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.NR-19878 is a split-virus vaccine prepared from influenza viruses A/Brisbane/59/2007 IVR-148 (H1N1), A/Uruguay/716/2007 NYMC X-175C (H3N2) [an A/Brisbane/10/2007 (H3N2)-like virus] and B/Brisbane/60/2008 that were predicted to circulate in the United States during the 2009 to 2010 influenza season.The hemagglutinin content was standardized according to U.S. Public Health Service requirements. Each 0.25 mL syringe contains the recommended ratio of 7.5 ?g each of the hemagglutinin antigens from influenza viruses A/Brisbane/59/2007 IVR-148 (H1N1), A/Uruguay/716/2007 NYMC X-175C (H3N2) and B/Brisbane/60/2008.Please note that this vaccine preparation is being released for research use only and not for human use. Vaccines produced for the 2009-2010 season are now past their expiration dates.Each syringe contains 0.25 mL of split-virus vaccine in phosphate-buffered saline containing 0.05% gelatin. The product was formulated without preservatives.